Literature DB >> 11035998

Statistical issues in toxicokinetic modeling: a bayesian perspective.

P Bernillon1, F Y Bois.   

Abstract

Determining the relationship between an exposure and the resulting target tissue dose is a critical issue encountered in quantitative risk assessment (QRA). Classical or physiologically based toxicokinetic (PBTK) models can be useful in performing that task. Interest in using these models to improve extrapolations between species, routes, and exposure levels in QRA has therefore grown considerably in recent years. In parallel, PBTK models have become increasingly sophisticated. However, development of a strong statistical foundation to support PBTK model calibration and use has received little attention. There is a critical need for methods that address the uncertainties inherent in toxicokinetic data and the variability in the human populations for which risk predictions are made and to take advantage of a priori information on parameters during the calibration process. Natural solutions to these problems can be found in a Bayesian statistical framework with the help of computational techniques such as Markov chain Monte Carlo methods. Within such a framework, we have developed an approach to toxicokinetic modeling that can be applied to heterogeneous human or animal populations. This approach also expands the possibilities for uncertainty analysis. We present a review of these efforts and other developments in these areas. Appropriate statistical treatment of uncertainty and variability within the modeling process will increase confidence in model results and ultimately contribute to an improved scientific basis for the estimation of occupational and environmental health risks.

Entities:  

Mesh:

Year:  2000        PMID: 11035998     DOI: 10.1289/ehp.00108s5883

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  28 in total

Review 1.  Whole body pharmacokinetic models.

Authors:  Ivan Nestorov
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 2.  Combining the 'bottom up' and 'top down' approaches in pharmacokinetic modelling: fitting PBPK models to observed clinical data.

Authors:  Nikolaos Tsamandouras; Amin Rostami-Hodjegan; Leon Aarons
Journal:  Br J Clin Pharmacol       Date:  2015-01       Impact factor: 4.335

3.  Preclinical pharmacology of novel indolecarboxamide ML-970, an investigative anticancer agent.

Authors:  Elizabeth Rayburn; Wei Wang; Mao Li; Xu Zhang; Hongxia Xu; Haibo Li; Jiang-Jiang Qin; Lee Jia; Joseph Covey; Moses Lee; Ruiwen Zhang
Journal:  Cancer Chemother Pharmacol       Date:  2012-02-25       Impact factor: 3.333

4.  Application of Markov chain Monte Carlo analysis to biomathematical modeling of respirable dust in US and UK coal miners.

Authors:  Lisa M Sweeney; Ann Parker; Lynne T Haber; C Lang Tran; Eileen D Kuempel
Journal:  Regul Toxicol Pharmacol       Date:  2013-02-27       Impact factor: 3.271

5.  Modeling and Simulation of Pretomanid Pharmacodynamics in Pulmonary Tuberculosis Patients.

Authors:  Michael A Lyons
Journal:  Antimicrob Agents Chemother       Date:  2019-09-30       Impact factor: 5.191

6.  Bayesian evaluation of a physiologically-based pharmacokinetic (PBPK) model of long-term kinetics of metal nanoparticles in rats.

Authors:  Lisa M Sweeney; Laura MacCalman; Lynne T Haber; Eileen D Kuempel; C Lang Tran
Journal:  Regul Toxicol Pharmacol       Date:  2015-07-03       Impact factor: 3.271

7.  Computational pharmacokinetics/pharmacodynamics of rifampin in a mouse tuberculosis infection model.

Authors:  Michael A Lyons; Anne J Lenaerts
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-05-31       Impact factor: 2.745

8.  Comparing models for perfluorooctanoic acid pharmacokinetics using Bayesian analysis.

Authors:  John F Wambaugh; Hugh A Barton; R Woodrow Setzer
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-01-08       Impact factor: 2.745

9.  A Bayesian population PBPK model for multiroute chloroform exposure.

Authors:  Yuching Yang; Xu Xu; Panos G Georgopoulos
Journal:  J Expo Sci Environ Epidemiol       Date:  2009-05-27       Impact factor: 5.563

10.  Population toxicokinetic modeling of cadmium for health risk assessment.

Authors:  Billy Amzal; Bettina Julin; Marie Vahter; Alicja Wolk; Gunnar Johanson; Agneta Akesson
Journal:  Environ Health Perspect       Date:  2009-05-06       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.